India, May 29 -- image credit- shutterstock

Sequent Scientific (SeQuent), a Mumbai-based player in the global animal health industry, has secured approvals from both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) for its proposed merger with Hyderabad-based Viyash Life Sciences (Viyash). The company has now filed for clearance with the National Company Law Tribunal (NCLT), marking a crucial milestone in the merger process.

The merger will bring together two strong business verticals-Global Animal Health and a world class integrated API business unlocking access to over 150 countries. The combined entity will benefit from a five-fold increase in R&D talent and a nine-fold expansion in USFDA-approved manufacturing c...